HB 1280-FN (2020): relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“HB 1280-FN (2020): relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors.” Granite Record, https://graniterecord.org/bill/2020/hb1280. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). HB 1280-FN (2020): relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb1280
Chicago
Granite Record. “HB 1280-FN (2020): relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb1280.
BibTeX
@misc{bill-2020-hb1280, title = {HB 1280-FN (2020): relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb1280}, note = {Accessed 24 Oct. 2026} }

HB 1280-FN (2020)

relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors.

  • Status: Signed into law
  • Term: 2019-2020
  • House committee: Commerce and Consumer Affairs
  • Senate committee: Commerce
  • Subject: Insurance
  • Chapter law: 13

The Story

It was introduced on January 8, 2020 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on January 21, 2020. The committee held a work session on January 30, 2020. The committee met in executive session on February 4, 2020 to vote on its recommendation. The committee held work sessions on February 18, 2020 and February 24, 2020. The committee met in executive session on March 3, 2020 to vote on its recommendation. The minority of the committee recommended that the House study it after the session ends. The majority of the committee recommended that the House pass it with changes (amendment 2020-0105h) by a vote of 12–8, and the report was placed on the regular calendar. The committee's amendment (2020-0105h) was adopted on a voice vote on March 11, 2020, changing the text of the bill. On March 11, 2020 the House voted to pass it with changes on a roll call 223–121. It crossed to the Senate on March 12, 2020 and was referred to the Senate Commerce committee. The committee recommended that the Senate pass it with changes (amendment 2020-1470s). The committee's amendment (2020-1470s) was adopted on a voice vote on June 16, 2020, changing the text of the bill. On June 16, 2020 the Senate voted to pass it with changes and ordered it to a third reading. On June 30, 2020 the House adopted “House Concurs with Senate Amendment” on a roll call 224–104, on a motion by Rep. Billie Butler. The bill was enrolled on June 30, 2020 — the final check of the text before it goes to the governor — and an enrolled bill amendment (2020-1631) was adopted on a voice vote to correct technical errors found after passage. The bill was enrolled on July 14, 2020 — the final check of the text before it goes to the governor — and an enrolled bill amendment (2020-1631e) was adopted on a voice vote to correct technical errors found after passage. The governor signed it on July 16, 2020, making it Chapter 13 of the session laws.

Sponsors

Hearings and Sessions

  • January 21, 2020, 10:00 AM: public hearing, House Commerce and Consumer Affairs, LOB 302
  • January 30, 2020, 1:00 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • February 4, 2020, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB 302
  • February 18, 2020, 9:30 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • February 24, 2020, 9:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • March 3, 2020, 10:30 AM: executive session, House Commerce and Consumer Affairs, LOB 302
  • June 5, 2020, 9:00 AM: hearing, Senate Commerce

Votes

  • March 11, 2020, House: Ought to Pass with Amendment — yeas 223, nays 121, passed
  • June 16, 2020, Senate: Ought to Pass with Amendment — yeas 24, nays 0, passed
  • July 1, 2020, House: Concur — yeas 224, nays 104, passed

The Docket

  • January 8, 2020: Introduced 01/08/2020 and referred to Commerce and Consumer Affairs
  • January 21, 2020: Public Hearing: 01/21/2020 10:00 am LOB 302
  • January 30, 2020: Subcommittee Work Session: 01/30/2020 01:00 pm LOB 302
  • February 4, 2020: Executive Session: 02/04/2020 10:00 am LOB 302
  • February 18, 2020: Subcommittee Work Session: 02/18/2020 09:30 am LOB 302
  • February 24, 2020: Subcommittee Work Session: 02/24/2020 09:00 am LOB 302
  • March 3, 2020: Executive Session: 03/03/2020 10:30 am LOB 302
  • March 4, 2020: Minority Committee Report: Refer for Interim Study
  • March 11, 2020: Majority Committee Report: Ought to Pass with Amendment #2020-0105h for 03/11/2020 (Vote 12-8; RC)
  • March 11, 2020: Amendment #2020-0105h : AA VV 03/11/2020
  • March 11, 2020: Ought to Pass with Amendment 2020-0105h: MA RC 223-121 03/11/2020
  • March 12, 2020: Introduced 03/12/2020 and Referred to Commerce
  • June 2, 2020: Remote Hearing: 06/05/2020, 09:00 am; SC 21B
  • June 2, 2020: Remote Hearing: 06/05/2020, 09:05 am, on proposed amendment #2020-1298s ; SC 21B
  • June 2, 2020: Committee members will receive secure Zoom invitations via email. SC 21B
  • June 2, 2020: Members of the public may attend using the following links: SC 21B
  • June 2, 2020: 1. To sign-in and/or speak in support or opposition, please register in advance by using this link: https://www.zoom.us/webinar/register/WN_jolWTc_BQC6QKTVDcC5zSw SC 21B
  • June 2, 2020: 2. To submit your testimony to the committee, please send all documents via email to [email protected] SC 21B
  • June 2, 2020: 3. To listen via telephone: Dial (for higher quality, dial a number based on your current location): 1-301-715-8592, or 1-312-626-6799 or 1-929-205-6099, or 1-253-215-8782, or 1-346-248-7799, or 1-669-900-6833 SC 21B
  • June 2, 2020: 4. Or iPhone one-tap: 13017158592,,97349298372# or 13126266799,,97349298372# SC 21B
  • June 2, 2020: 5. Webinar ID: 973 4929 8372 SC 21B
  • June 2, 2020: 6. To view/listen to this hearing on YouTube, use this link: https://www.youtube.com/channel/UCjBZdtrjRnQdmg-2MPMiWrA SC 21B
  • June 2, 2020: The following email will be monitored throughout the meeting by someone who can assist with and alert the committee to any technical issues: [email protected] or call (603-271-3043). SC 21B
  • June 16, 2020: Committee Report: Ought to Pass with Amendment #2020-1470s , 06/16/2020
  • June 16, 2020: Committee Amendment #2020-1470s , AA, VV; 06/16/2020
  • June 16, 2020: Ought to Pass with Amendment 2020-1470s, RC 24Y-0N, MA; OT3rdg; 06/16/2020
  • June 30, 2020: House Concurs with Senate Amendment (Rep. Butler): MA RC 224-104 06/30/2020
  • June 30, 2020: Enrolled Bill Amendment #2020-1631: AA VV 06/30/2020
  • June 30, 2020: Enrolled 06/30/2020
  • July 10, 2020: Enrolled Bill Amendment #2020-1631e Adopted, VV, (In recess of 06/29/2020)
  • July 14, 2020: Enrolled (In recess 06/29/2020)
  • July 16, 2020: Signed by Governor Sununu 07/16/2020; Chapter 13; I. Sec. 5 Eff: 07/01/2020 II. Sec. 12 and 14 Eff: 01/01/2021 at 12:04am III. Sec 8/9-11 Eff: 01/01/2021 IV. Sec. 1-4/6 and 13 Eff: 09/14/2020 V. Rem. Eff: 07/16/2020

Laws It Would Change

Related Bills

  • SB 687-FN (2020): relative to transparency in prescription drug pricing and establishing a New Hampshire prescription drug affordability board.
  • SB 687-FN (2020): relative to transparency in prescription drug pricing and establishing a New Hampshire prescription drug affordability board.

From the General Court